Sirtuin Deacetylases: A New Target for Melanoma Management

Cell Cycle - United States
doi 10.4161/15384101.2014.949085
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Cloning, Chromosomal Characterization and Mapping of the NAD-dependent Histone Deacetylases Gene Sirtuin 1

International Journal of Molecular Medicine
MedicineGenetics
2006English

Adenosine Mimetics as Inhibitors of NAD+-Dependent Histone Deacetylases, From Kinase to Sirtuin Inhibition

English

Autophagy- An Emerging Target for Melanoma Therapy

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2016English

Role of Sirtuin 1 in Regulation of Melanoma Cell Proliferation

Siberian Journal of Oncology
Cancer ResearchOncology
2020English

Treat to Target: A Proposed New Paradigm for the Management of Crohn's Disease

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2015English

Identification of a Class of Small Molecule Inhibitors of the Sirtuin Family of NAD-dependent Deacetylases by Phenotypic Screening

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

Potential of PCSK9 as a New Target for the Management of LDL Cholesterol

Research Reports in Clinical Cardiology
2015English

Is Brca-Associated Protein (Bap1) a New Drug Target to Combat Metastatic Uveal Melanoma?

Open Access Journal of Toxicology
2018English

Neuropilin-1 as Therapeutic Target for Malignant Melanoma

Frontiers in Oncology
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy